Kennedy Appears Ill-Informed On Major Pharma Priorities, Creating Unique Lobbying Dynamics

Robert F. Kennedy Jr.
HHS Secretary Robert F. Kennedy Jr.'s lack of knowledge on key industry policy asks may impact lobbying strategy. (lev radin / Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from US FDA